David Soergel's Insider Trades & SAST Disclosures

David Soergel's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 12,839 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Madrigal Pharmaceuticals Inc
David Soergel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2025 12,839 12,839 - - Stock Option (Right to Buy)
Madrigal Pharmaceuticals Inc
David Soergel Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2025 7,545 7,545 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades